Related Experiment Video
Updated: Jun 15, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Therapeutic approaches targeting seizure networks
Jenna Langbein1, Ujwal Boddeti1,2, Matthew Kreinbrink1
1Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States.
Drug-resistant epilepsy (DRE) affects millions globally. Targeting pathological seizure networks, not just focal points, may improve surgical outcomes for patients with DRE.
Area of Science:
- Neurology
- Neurosurgery
- Epileptology
Background:
- Epilepsy is a common neurological disorder affecting over 65 million people worldwide.
- A significant portion of patients (over one-third) have drug-resistant epilepsy (DRE) despite anti-seizure medications (ASMs).
- Current surgical interventions for DRE have limited success, with over 50% of patients experiencing refractory seizures post-surgery.
Purpose of the Study:
- To review current surgical management strategies for epilepsy.
- To explore hypothesized mechanisms of treatment failure in epilepsy surgery.
- To discuss the potential of seizure network theory to improve surgical outcomes.
Main Methods:
- This study presents a narrative review of existing literature on surgical epilepsy management.
- It examines current surgical interventions and their hypothesized mechanisms of failure.
- Evidence supporting pathological seizure networks is highlighted.
Main Results:
- Treatment failure in epilepsy surgery may stem from targeting only focal areas rather than the entire pathological seizure network.
- A shift towards understanding epilepsy as a network disorder is emerging.
- Current surgical approaches may not adequately address the complex network dynamics.
Conclusions:
- The network theory of epilepsy offers a new framework for surgical management.
- Targeting seizure networks, rather than isolated foci, could lead to improved seizure control.
- Adapting surgical practices and neuromodulatory interventions to target networks may offer novel therapeutic strategies for DRE.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

